Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03256227 · ClinicalTrials.gov registry record · NA
Improving Veteran Adherence to Treatment for PTSD Through Partnering With Families
A NA study, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- NA
- Development phase
- 128
- Enrollment target
NCT03256227: Completed NA study, sponsored by VA Office of Research and Development.
NCT03256227 is a NA study that has completed, run by VA Office of Research and Development. The registered enrollment target is 128 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03256227, a NA study, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- NA
- Development phase
- 128 participants
- Enrollment target
Study Summary
Evidence-based psychotherapies (EBP) for PTSD, such as Prolonged Exposure (PE), result in clinically significant symptom relief for many. Yet, adherence to this treatment (i.e., session attendance and homework compliance), which is vital to ensuring recovery, can be poor. This project will test the effectiveness of improving family support for PE as a tool to improve Veterans' PE adherence. Reducing rates of dropout from PE will positively impact Veterans' health and well-being and lower the cost of treating PTSD. Additionally, despite congressional legislation and national mandates within VA/DoD for family involvement in PTSD care, there remains no proven strategies for how to routinely include family in traditional individual (i.e., one-on-one) EBPs for PTSD. This proposal will provide the initial test of a model of family engagement that can be translated to other problems faced by Veterans, including suicide prevention, traumatic brain injury (TBI) rehabilitation, and pain management, contributing to a broader evolution towards evidence-based, family-inclusive care.
Interventions
- BEHAVIORAL Family Supported Prolonged Exposure
- BEHAVIORAL Standard Prolonged Exposure
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 128 participants |
| Start Date | 2018-01-15 |
| Est. Completion | 2022-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03256227
The ClinicalTrials.gov registry entry for NCT03256227 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 128 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Family Supported Prolonged Exposure is the first listed.
NCT03256227 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03256227 about?
NCT03256227 is a clinical study titled "Improving Veteran Adherence to Treatment for PTSD Through Partnering With Families". Evidence-based psychotherapies (EBP) for PTSD, such as Prolonged Exposure (PE), result in clinically significant symptom relief for many. Yet, adherence to this treatment (i.e., session attendance and homework compliance), which is vital to ensuring recovery, can be poor. This project will test the ...
What is the current status of trial NCT03256227?
This trial is currently completed. It is a NA study. The enrollment target is 128 participants. The study started on 2018-01-15. Estimated completion is 2022-06-30.
What interventions are being tested in trial NCT03256227?
The interventions under investigation include: Family Supported Prolonged Exposure (BEHAVIORAL), Standard Prolonged Exposure (BEHAVIORAL).
Who is sponsoring clinical trial NCT03256227?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.